Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00410449 · ClinicalTrials.gov registry record
Oxidative Stress and Hemodialysis Access Failure
A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
- 35
- Enrollment target
NCT00410449 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). The registered enrollment target is 35 participants.
The verdict
NCT00410449 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Complications of hemodialysis access are the most frequent single reason for hospitalization among patients with End Stage Renal Disease (ESRD). Uremia, and particularly uremia in patients with diabetes, is a state of increased oxidative stress. The central hypothesis to be tested by this project is that oxidative stress is a major (and modifiable) trigger for vascular access complications. We hope to slow or reduce rates of stenosis, thrombosis and access complications by giving Vitamin E supplementation to patients being treated by hemodialysis.
Interventions
- DRUG Alpha tocopherol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2001-05 |
| Est. Completion | 2004-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00410449
The ClinicalTrials.gov registry entry for NCT00410449 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alpha tocopherol is the first listed.
NCT00410449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00410449 about?
NCT00410449 is a clinical study titled "Oxidative Stress and Hemodialysis Access Failure". Complications of hemodialysis access are the most frequent single reason for hospitalization among patients with End Stage Renal Disease (ESRD). Uremia, and particularly uremia in patients with diabetes, is a state of increased oxidative stress. The central hypothesis to be tested by this project is...
What is the current status of trial NCT00410449?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2001-05. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00410449?
The interventions under investigation include: Alpha tocopherol (DRUG).
Who is sponsoring clinical trial NCT00410449?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.